The replacement of the Omicron BA. 1 variant of SARS-CoV-2 by the BA. 2 and the rapid
growth of the BA. 5 sub lineage, which have both different sets of mutations in the spike …

The emergence and rapid spread of the Omicron variant of SARS-CoV-2, which has more
than 30 substitutions in the spike glycoprotein, compromises the efficacy of currently …

Abstract As of May 2022, Omicron BA. 2 variant is the most dominant variant in the world.
Thereafter, Omicron subvariants have emerged and some of them began outcompeting BA …

The recent emergence of the Omicron BA. 1 and BA. 2 variants with heavily mutated spike
proteins has posed a challenge to the effectiveness of current vaccines and to monoclonal …

The emergence of the highly transmissible B. 1.1. 529 Omicron variant of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody …

ABSTRACT SARS-CoV-2 Omicron variants contain many mutations in its spike receptor-
binding domain, the target of all authorized monoclonal antibodies (MAbs). Determining the …

The landscape of SARS-CoV-2 variants dramatically diversified with the simultaneous
appearance of multiple subvariants originating from BA. 2, BA. 4, and BA. 5 Omicron sub …

Monoclonal antibody therapy for the treatment of SARS-CoV-2 infection has been highly
successful in decreasing disease severity; however, the recent emergence of the heavily …

Newly emerging SARS-CoV-2 variants may escape monoclonal antibodies (mAbs) and
antiviral drugs. By using live virus assays, we assessed the ex vivo inhibition of the B. 1 wild …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant
BA. 2.75 emerged recently and appears to be spreading. It has nine mutations in spike …